These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6530355)

  • 41. Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity.
    Logan TF; Robertson MJ
    Curr Oncol Rep; 2006 Mar; 8(2):114-9. PubMed ID: 16507221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reactions to drugs useful in cancer therapy].
    Dionne L
    Laval Med; 1968 Sep; 39(7):606-12. PubMed ID: 5744732
    [No Abstract]   [Full Text] [Related]  

  • 43. [Towards immunopharmacology].
    Moulias R; Simon P
    Nouv Presse Med; 1976 Feb; 5(7):439-41. PubMed ID: 1257042
    [No Abstract]   [Full Text] [Related]  

  • 44. A theory of the action of cancer chemotherapeutic drugs.
    Rose S
    Clin Exp Immunol; 1967 May; 2(3):361-73. PubMed ID: 5340665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of nutrition and treatment of cancer on host immunocompetence.
    Ota DM; Copeland EM; Corriere JN; Dudrick SJ
    Surg Gynecol Obstet; 1979 Jan; 148(1):104-11. PubMed ID: 364703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunological aspects of anticancer chemotherapy].
    Zitvogel L; Tesniere A; Apetoh L; Ghiringhelli F; Kroemer G
    Bull Acad Natl Med; 2008 Oct; 192(7):1469-87; discussion 1487-9. PubMed ID: 19445369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The drug-immune system interaction in cancer therapy.
    Ghione M
    Int J Tissue React; 1984; 6(6):513-21. PubMed ID: 6530355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 49. Twelve immunotherapy drugs that could cure cancers.
    Cheever MA
    Immunol Rev; 2008 Apr; 222():357-68. PubMed ID: 18364014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
    Snook AE; Eisenlohr LC; Rothstein JL; Waldman SA
    Clin Pharmacol Ther; 2007 Dec; 82(6):734-9. PubMed ID: 17898707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.